Cancer Family
Head and Neck Hematopoietic and Lymphoid Cell Neoplasm
CI-CAN-00000192Explore in graph →
HematologicNon-malignant3 active trials
- NCIt
- C202954
Loading cancer entity…
Cancer Family
CI-CAN-00000192Explore in graph →
Clinical trials
7 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07583810 | Non-covalent BTK Inhibitor Nemtabrutinib in Combination With the CD20 Monoclonal Antibody Rituximab for the Treatment of Marginal Zone Lymphoma | recruiting | Phase 2 | 35 | City of Hope Medical CenterOTHER | 1 | Sep 29, 2026 | clinicaltrials |
| NCT02494700 | Ultra Low Dose Orbital Radiation Therapy in Treating Patients With Stage I-IV Indolent B-cell Lymphoma or Mantle Cell Lymphoma | active not recruiting | Phase 2 | 50 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 15, 2026 | clinicaltrials |
| NCT07210749 | Radiotherapy 12Gy in 6 Fractions For Orbital Lymphoma | not yet recruiting | N/A | 36 | British Columbia Cancer AgencyOTHER | 1 | Oct 7, 2025 | clinicaltrials |
| NCT05696314 |
Data updated yesterdaySource updated Sep 29, 2026source: clinicaltrials
| completed |
| N/A |
| 201 |
| Rigshospitalet, DenmarkOTHER |
| 1 |
| Oct 3, 2024 |
| clinicaltrials |
| NCT05698667 | Outpatient Ultrasound for the Diagnostic Work-up of Oropharynx Cancer | completed | N/A | 26 | Rigshospitalet, DenmarkOTHER | 1 | May 6, 2023 | clinicaltrials |
| NCT01514344 | Intralesional Rituximab for the Treatment of Conjunctival Indolent Lymphoma(IRIS) | completed | Phase 2 | 20 | Andres J. M. FerreriOTHER | 1 | Aug 4, 2022 | clinicaltrials |
| NCT01302912 | Lymphoma in the Orbit | unknown | — | 50 | University of ZurichOTHER | 1 | Nov 4, 2011 | clinicaltrials |